Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OXY vs GSK✓SelectedUSD · GSKOXY vs GSK performance historyLatest closeAs of+0.60%11/13
Stock and ETF performance explorer

OXY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.5%
GSK return
+44.4%
Excess return
+53.0%
Maximum drawdown
-50.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%+0.5%+0.1%+0.6%
7D+4.2%+1.1%+3.1%+4.1%
30D-4.3%+6.3%-10.7%-4.7%
3M+2.3%+1.8%+0.5%+2.1%
6M+5.5%+1.7%+3.9%+5.2%
YTD+44.9%+6.5%+38.3%+42.6%
1Y+42.6%+9.5%+33.1%+39.9%
3Y+0.7%+65.3%-64.6%-7.7%
All+97.5%+44.4%+53.0%+79.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling